Press Release

AI & Quantum Physics-based technologies are reforming conventional drug development.

AI & Quantum Physics-based technologies are reforming conventional drug development. 더 읽기"

The evolution of AI drug development : “Generation of mRNA vaccine candidates in 24 hours”

The evolution of AI drug development : “Generation of mRNA vaccine candidates in 24 hours” 더 읽기"

[CEO interview] Combining AI and Quantum Mechanics to Improve Drug and Vaccine Discovery

[CEO interview] Combining AI and Quantum Mechanics to Improve Drug and Vaccine Discovery 더 읽기"

“PharmCADD will be the 1st AI-based drug discovery company that commercializes a medicine.”, said CEO.

“PharmCADD will be the 1st AI-based drug discovery company that commercializes a medicine.”, said CEO. 더 읽기"

PharmCADD announced a licensing agreement of AI-based anti-cancer drug with REDIPHARM.

PharmCADD announced a licensing agreement of AI-based anti-cancer drug with REDIPHARM. 더 읽기"

PharmCADD signed MOU with Qunova to develop new drug utilizing Quantum Computing.

PharmCADD signed MOU with Qunova to develop new drug utilizing Quantum Computing. 더 읽기"

“PharmCADD will be the first case to commercialize AI-generated COVID19 vaccine.”, said CEO.

“PharmCADD will be the first case to commercialize AI-generated COVID19 vaccine.”, said CEO. 더 읽기"

PharmCADD is growing to be a global company.

PharmCADD is growing to be a global company. 더 읽기"

PharmCADD participated in 2022 Global IR @JPM Virtual Demo Day.

PharmCADD participated in 2022 Global IR @JPM Virtual Demo Day. 더 읽기"

“The first AI-based mRNA vaccine will be launched into the world in 2022.” said PharmCADD CEO.

“The first AI-based mRNA vaccine will be launched into the world in 2022.” said PharmCADD CEO. 더 읽기"